Today I read an interesting article in Bayer's newsletter. Yes, that's exactly what I mean, the pharmaceutical giant Bayer. Now you're getting suspicious, aren't you? The article is about a groundbreaking, groundbreaking advance in Parkinson's therapy. Probably a new drug that only works on the surface, costs a lot of money and just takes money out of people's pockets.
But what struck me about this article is a small side note that is at least as groundbreaking as the information that cell and gene therapy can be used to reprogram human cells and could lead to Parkinson's being banished from the body . Early clinical studies are being conducted with promising results. That is very gratifying! But that also means that many more studies and tests are needed before we patients can benefit from them.
So much for the little discourse on the subject of the article. Now I need your full attention. Concentration! Well, the first paragraph of the article says in a small subordinate clause that Parkinson's is the world's most common neurodegenerative movement disorder.
Roger that?
Parkinson's is the most common neurodegenerative movement disorder worldwide. Not the second most common or similar to others. No, she has the sole claim to the title. So now the authors of the article just throw this chunk of information without warning – plop – in front of our feet!
But what does this information mean? Shall we pat each other on the back and congratulate on the success? Finally we are no longer the ungrateful second. Hooray, Parkinson's made it and easily overtook Alzheimer's - we're champions! Yes master of what?
I think we can actually be happy about this information. Because now states are waking up, governments and organizations are realizing that we have become a dangerous economic factor. Who would like to sit down and calculate how many costs we incur - if only because of the fact that, despite Parkinson's, we hardly die earlier than others. The expensive drugs and therapies, the hospital stays, the aids and last but not least the loss of our work performance and our purchasing power. Tragic that we are getting younger and younger!
This fact has already been recognized by the WHO and Parkinson's has been included in the intersectoral action plan, where epilepsy and other neurodegenerative diseases have been treated as a priority for years. And a few weeks ago, American lawmakers from both parties submitted a joint bill to combat Parkinson's.
I ask myself, when will German politics wake up? When will the German Parkinson's organizations begin to take serious public relations measures? Hopefully it will be quicker than the introduction of stem cells Therapy.
Hamburg, August 06.08.2022th, XNUMX, May Evers
All articles from the column "To know better!"
Green environments have a positive effect on Parkinson's disease
Breakthrough in Parkinson's diagnostics
Stem cell therapy for people with Parkinson's disease
Parkinson's and art
Mission Parkinson
The Angry Professor's Appeal
I've read a few articles and I have to agree with a lot. A professor in Aachen said something true to me: We don't know where Parkinson's comes from, why cells die. You grab the big hammer (dopamine) and hit it, and see what happens. Does it then continue with it, if not something else is tried. Is garnix more then THS, hooray success.